We are live on ! Find out more
ACM

Abrams Capital Management Portfolio holdings

AUM $4.64B
1-Year Est. Return 1.52%
This Fund
S&P 500
This Quarter Est. Return
+18.01%
1 Year Est. Return
-1.52%
3 Year Est. Return
+72.02%
5 Year Est. Return
+85.41%
10 Year Est. Return
+362.14%
AUM
$3.48B
AUM Growth
+$316M
Cap. Flow
-$207M
Cap. Flow %
-5.96%
Top 10 Hldgs %
88.81%
Holding
17
New
1
Increased
Reduced
4
Closed

Sector Composition

1 Consumer Discretionary 50.22%
2 Communication Services 17.39%
3 Industrials 14.03%
4 Energy 6.51%
5 Financials 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAD icon
1
Lithia Motors
LAD
$7.73B
$715M 20.56%
2,351,068
ABG icon
2
Asbury Automotive
ABG
$4.22B
$507M 14.58%
2,108,540
META icon
3
Meta Platforms (Facebook)
META
$1.69T
$327M 9.39%
1,138,126
-1,013,732
-47% -$250M
TDG icon
4
TransDigm Group
TDG
$68.9B
$280M 8.04%
312,747
-53,440
-15% -$42.3M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.33T
$278M 7.99%
2,322,340
-17,100
-0.7% -$1.97M
CPNG icon
6
Coupang
CPNG
$30.3B
$227M 6.51%
13,017,964
-422,000
-3% -$6.88M
ET icon
7
Energy Transfer Partners
ET
$69.5B
$226M 6.51%
17,834,322
WTW icon
8
Willis Towers Watson
WTW
$27.8B
$190M 5.46%
806,836
UHAL.B icon
9
U-Haul Holding Co Series N
UHAL.B
$12.4B
$186M 5.34%
3,663,243
CWH icon
10
Camping World
CWH
$415M
$154M 4.42%
5,108,808
SGI
11
Somnigroup International
SGI
$15.8B
$144M 4.15%
3,600,000
HZNP
12
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$91.6M 2.64%
+890,993
New +$94M
TEVA icon
13
Teva Pharmaceuticals
TEVA
$37.5B
$60M 1.73%
7,966,433
CTLP
14
DELISTED
Cantaloupe
CTLP
$57.2M 1.64%
7,180,000
UHAL icon
15
U-Haul Holding Co
UHAL
$14.1B
$22.5M 0.65%
407,027
NUVB icon
16
Nuvation Bio
NUVB
$1.96B
$6.86M 0.2%
3,811,513
USCB icon
17
USCB Financial Holdings
USCB
$382M
$6.62M 0.19%
649,085

Similar funds

Abrams Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Abrams Capital Management held 17 positions worth $3.48B, up 10% from $3.16B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Abrams Capital Management withdrew a net $207M in Q2 2023, reducing 4 holdings. Its largest reduction was Meta Platforms (Facebook), cutting an estimated $250M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 46% a quarter earlier, followed by Communication Services and Industrials.

Against the trend, Abrams Capital Management opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $91.6M.

  • Abrams Capital Management's largest Q2 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 890,993 shares worth $91.6M.
  • Abrams Capital Management's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $250M.
  • Abrams Capital Management's ten largest holdings make up 89% of its $3.48B portfolio in Q2 2023.
  • Abrams Capital Management opened 1 new position and closed 0 in Q2 2023.
  • Abrams Capital Management's portfolio value rose 10% quarter-over-quarter to $3.48B.

Based on Abrams Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.